Abstract
The ability to monitor for chemical carcinogen-DNA adducts in human tissues provides an indication that human exposure has occurred. Such data may eventually demonstrate the dose received and/or allow the prediction of cancer risk. At the present time evidence that the occurrence of certain adducts is associated with specific chemical exposures is accumulating, and multiple methods are being validated to confirm these observations.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Barnhart, K. M. and Bowden, G. T., 1985, Cisplatin as an initiating agent in two-stage mouse skin carcinogenesis, Cancer Lett., 29: 101.
Butler, J. E., 1980, Antibody-antigen and antibody-hapten reactions, in: “Enzyme-Immunoassay”, E. T. Maggio, ed., CRC Press, Inc., Boca Raton, p 6.
Calvert, A. H., 1986, Clinical application of platinum metal complexes, in: “Biochemical Mechanisms of Platinum Antitumor Drugs”, D. C. H. McBrien and T. F. Slater, eds., IRL Press, Oxford, p 307.
Einhorn, L. H., Donohue, J. P., Peckham, M. J., Williams, S. D., and Loehrer, P. J., 1985, Cancer of the testes, in: “Cancer - Principles and Practice of Oncology”, V. T. DeVita, S. Hellman, and S. A. Rosenberg, eds., Lippincott, Philadelphia, p 979.
Engvall, E., 1980, Enzyme immunoassay ELISA and EMIT, Methods in Enzymology, 70: 419.
Erlanger, B. F., 1980, The preparation of antigenic hapten-carrier conjugates: A survey, Methods in Enzymology, 70: 85.
Groopman, J.D., Trudel, L. J., Donahue, P. R., Marshak-Rothstein, A., and Wogan, G. N., 1984, High-affinity monoclonal antibodies for aflatoxins and their application to solid-phase immunoassays, Proc. Natl. Acad. Sci. USA, 81: 7728.
Leopold, W. R., Miller, E. C., and Miller, J. A., 1979, Carcinogenicity of antitumor cis-platinum(II) coordination complexes in the mouse and rat, Cancer Res., 39: 913.
Lippard, S. J., Ushay, H. M., Merkel, C. M., and Poirier, M. C., 1983, Use of antibodies to probe the stereochemistry of antitumor platinum drug binding to deoxyribonucleic acid, Biochemistry, 22: 5165.
Müller, R. and Rajewsky, M. F., 1981, Antibodies specific for DNA components structurally modified by chemical carcinogens, J. Cancer Res. Clin. Oncol., 102: 99.
Perera, F. P., Poirier, M. C., Yuspa, S. H., Nakayama, J., Jaretzki, A., Curnen, M. M., Knowles, D. M., and Weinstein, I. B., 1982, A pilot project in molecular cancer epidemiology: Determination of benzo[a]pyrene-DNA adducts in animal and human tissues by immunoassays, Carcinogenesis, 3: 1405.
Plooy, A. C. M., Fichtinger-Schepman, A. M. J., Schutte, H. H., van Dijk, M., and Lohman, P. H. M., 1985, The quantitative detection of various Pt-DNA-adducts in Chinese hamster ovary cells treated with cisplatin: application of immunochemical techniques, Carcinogenesis, 6: 561.
Poirier, M. C., Santella, R., Weinstein, I. B., Grunberger, D., and Yuspa, S. H., 1980, Quantitation of benzo(a)pyrene-deoxyguanosine adducts by radioimmunoassay, Cancer Research, 40: 412.
Poirier, M. C., 1981, Antibodies to carcinogen-DNA adducts, JNCI, 67: 515.
Poirier, M. C. and Connor, R. J., 1982, Radioimmunoassay for 2-acetylamino-fluorene-DNA adducts, Methods in Enzymology, 84: 607.
Poirier, M. C., Lippard, S. J., Zwelling, L. A., Ushay, H. M., Kerrigan, D., Thill, C. C., Santella, R. M., Grunberger, D., and Yuspa, S. H., 1982, Antibodies elicited against cis-diamminedichloroplatinum(II)- modified DNA are specific for cis-diamminedichloroplatinum(II)-DNA adducts formed in vivo and in vitro, Proc. Natl. Acad. Sci. USA, 9: 6443.
Poirier, M. C., 1984, The use of carcinogen-DNA adduct antisera for quantitation and localization of genomic damage in animal models and the human population, Environ. Mutagen, 6:879.
Poirier, M. C., Reed, E., Ozols, R. F., Fasy, T., and Yuspa, S. H., 1987, DNA adducts of cisplatin in nucleated peripheral blood cells and tissues of cancer patients, Prog. Exp. Tumor Res., 31:104.
Poirier, M. C., Egorin, M. J., Fichtinger-Schepman, A. M. J., and Reed, E., 1988, DNA adducts of cisplatin and carboplatin in tissues of human cancer patients, in: “Methods for Detecting Damaging Agents in Humans: Applications in Cancer Epidemiology and Prevention”, H. Bartsch, K. Hemminki, and I. K. O’Neill, eds., International Agency for Research on Cancer Scientific Publication No. 89, Lyon, p 313.
Poirier, M. C., 1990, Development of immunoassays for the detection of carcinogen-DNA adducts, in: “Monitoring Human Exposure to Carcinogens: Analytical, Epidemiological and Ethical Considerations” P. L. Skipper, F. Koshier, and J. D. Groopman, eds., Telford Press, Caldwell, in press.
Reed, E., Ostchega, Y., Steinberg, S. M., Yuspa, S. H., Young, R. C., Ozols, R. F., and Poirier, M. C., 1990, An evaluation of platinum-DNA adduct levels relative to known prognostic variables in a cohort of ovarian cancer patients, Carcinogenesis, in press.
Reed, E., Ozols, R. F., Tarone, R., Yuspa, S. H., and Poirier, M. C., 1987, Platinum-DNA adducts in leukocyte DNA correlate with disease response in ovarian cancer patients receiving platinum-based chemotherapy, Proc. Natl. Acad. Sci. USA, 84:5024.
Reed, E., Yuspa, S. H., Zwelling, L. A., Ozols, R. F., and Poirier, M. C., 1986, Quantitation of cis-diamminedichloroplatinum(II) (Cisplatin)- DNA intrastrand adducts in testicular and ovarian cancer patients receiving cisplatin chemotherapy. J. Clin. Invest., 77:545.
Santella, R. M., 1988, Application of new techniques for the detection of carcinogen adducts to human population monitoring, Mutation Research, 205:271.
Santella, R. M., Weston, A., Perera, F. P., Trivers, G. T., Harris, C. C., Young, T. L., Nguyen, D., Lee, B. M., and Poirier, M. C., 1988, Interlaboratory comparison of antisera and immunoassays for benzo[a]pyrene-diol-epoxide-I-modified DNA, Carcinogenesis, 9:1265.
Stollar, B. D., 1980, The experimental induction of antibodies to nucleic acids, Methods in Enzymology, 70:70.
Van Schooten, F. J., Kriek, E., Steenwinkel, M. S. T., Noteborn, H. P. J. M., Hillebrand, M. J. X., and Leeuwen, F. E. V., 1987, The binding efficiency of polyclonal and monoclonal antibodies to DNA modified with benzo[a]pyrene diol epoxide is dependent on the level of modification. Implications for quantitation of benzo[a]pyrene-DNA adducts in vivo, Carcinogenesis, 8:1263.
Weston, A., Manchester, D. K., Poirier, M. C., Choi, J.-S., Trivers, G.E., Mann, D. L., and Harris, C. C., 1989, Derivative fluorescence spectral analysis of polycyclic aromatic hydrocarbon-DNA adducts in human placenta, Chem. Res. Toxicol., 2:104.
Zettner, A., 1973, Principles of competitive binding assays (saturation analyses). I. Equilibrium techniques, Clin. Chem., 19:699.
Zettner, A. and Duly, P. E., 1974, Principles of competitive binding assays (saturation analyses). II. Sequential saturation, Clin. Chem., 20:5.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Plenum Press, New York
About this chapter
Cite this chapter
Poirier, M.C., Weston, A., Gupta-Burt, S., Reed, E. (1990). Measurement of DNA Adducts by Immunoassays. In: Sutherland, B.M., Woodhead, A.D. (eds) DNA Damage and Repair in Human Tissues. Basic Life Sciences, vol 53. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0637-5_1
Download citation
DOI: https://doi.org/10.1007/978-1-4613-0637-5_1
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-7903-7
Online ISBN: 978-1-4613-0637-5
eBook Packages: Springer Book Archive